As part of the company's vision to adding value to patients' lives, Nycomed Pharma Private Limited, a Nycomed Company, is committed to high quality research and development. within our global R&D network.
Two-thirds - or 20,000 - of the diseases and conditions known to medical science cannot be cured or treated adequately at the moment. This is why there will continue to be a great demand for new drugs which are both effective and safe.